Literature DB >> 28541274

Cerebrospinal fluid procalcitonin as a biomarker of bacterial meningitis in neonates.

Z Reshi1, M Nazir1, W Wani1, M Malik1, J Iqbal1, S Wajid1.   

Abstract

OBJECTIVE: The objective of the study was to study the performance of cerebrospinal fluid (CSF) procalcitonin as a marker for bacterial meningitis in neonates, and to determine its optimal 'cutoff' in CSF that can be called significant for the diagnosis. STUDY
DESIGN: Neonates qualifying for lumbar puncture were prospectively studied. Procalcitonin and established CSF parameters were recorded.
RESULTS: At a cut-off value of 0.33 ng ml-1, CSF procalcitonin had a sensitivity of 0.92, specificity of 0.87, with positive and negative likelihood ratios of 7.13 and 0.092, respectively. The area under the curve for different CSF parameters was: 0.926 (0.887 to 0.964) (P<0.001) for procalcitonin, 0.965 (0.956 to 0.974) for total leukocyte count, 0.961 (0.94 to 0.983) for neutrophil count, 0.874 (0.825 to 0.923) for protein, 0.946 (0.914 to 0.978) for sugar and 0.92 (0.955 to 0.992) for CSF:serum sugar ratio. The lumbar puncture was traumatic in 36 (21.4%) patients; out of these 15 (41.7%) had bacterial meningitis and 21 (58.3%) had no meningitis. In traumatic lumbar tap group, the median (IQR) CSF procalcitonin in patients with and without meningitis was 1.41 (0.32-3.42) ng/ml and 0.21(0.20-0.31) ng/ml respectively (p<0.05).
CONCLUSIONS: Procalcitonin measurement has diagnostic efficiency similar to the established CSF markers. Routine assessment of procalcitonin in clean non-contaminated CSF may not yield additional information, but it may have clinical utility in situations where diagnosis of meningitis is in dilemma, as in the case of blood contamination of CSF in traumatic lumbar punctures.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28541274     DOI: 10.1038/jp.2017.73

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  44 in total

Review 1.  Physiology and genetics of procalcitonin.

Authors:  P Maruna; K Nedelníková; R Gürlich
Journal:  Physiol Res       Date:  2000       Impact factor: 1.881

Review 2.  Clinical review 167: Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors.

Authors:  K L Becker; E S Nylén; J C White; B Müller; R H Snider
Journal:  J Clin Endocrinol Metab       Date:  2004-04       Impact factor: 5.958

3.  Corrections for leukocytes and percent of neutrophils do not match observations in blood-contaminated cerebrospinal fluid and have no value over uncorrected cells for diagnosis.

Authors:  Bema K Bonsu; Marvin B Harper
Journal:  Pediatr Infect Dis J       Date:  2006-01       Impact factor: 2.129

Review 4.  Neonatal meningitis.

Authors:  P T Heath; N K Nik Yusoff; C J Baker
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-05       Impact factor: 5.747

5.  Neonatal meningitis: what is the correlation among cerebrospinal fluid cultures, blood cultures, and cerebrospinal fluid parameters?

Authors:  Harmony P Garges; M Anthony Moody; C Michael Cotten; P Brian Smith; Kenneth F Tiffany; Robert Lenfestey; Jennifer S Li; Vance G Fowler; Daniel K Benjamin
Journal:  Pediatrics       Date:  2006-04       Impact factor: 7.124

6.  Bedside procalcitonin and C-reactive protein tests in children with fever without localizing signs of infection seen in a referral center.

Authors:  Annick Galetto-Lacour; Samuel A Zamora; Alain Gervaix
Journal:  Pediatrics       Date:  2003-11       Impact factor: 7.124

Review 7.  Procalcitonin as an early marker of infection in neonates and children.

Authors:  A M C van Rossum; R W Wulkan; A M Oudesluys-Murphy
Journal:  Lancet Infect Dis       Date:  2004-10       Impact factor: 25.071

8.  Diagnostic value of procalcitonin in well-appearing young febrile infants.

Authors:  Borja Gomez; Silvia Bressan; Santiago Mintegi; Liviana Da Dalt; Daniel Blazquez; Izaskun Olaciregui; Mercedes de la Torre; Miriam Palacios; Paola Berlese; Aitor Ruano
Journal:  Pediatrics       Date:  2012-10-29       Impact factor: 7.124

9.  Procalcitonin is elevated in the cerebrospinal fluid of patients with dementia and acute neuroinflammation.

Authors:  Andrea Ernst; Nils G Morgenthaler; Katharina Buerger; Richard Dodel; Carmen Noelker; Norbert Sommer; Markus Schwarz; Josef Koehrle; Andreas Bergmann; Harald Hampel
Journal:  J Neuroimmunol       Date:  2007-08-15       Impact factor: 3.478

Review 10.  Long-term neurodevelopmental outcomes after intrauterine and neonatal insults: a systematic review.

Authors:  Michael K Mwaniki; Maurine Atieno; Joy E Lawn; Charles R J C Newton
Journal:  Lancet       Date:  2012-01-13       Impact factor: 79.321

View more
  4 in total

1.  An improved clinical prediction rule for identifying neonatal bacterial meningitis: a multicenter cohort study.

Authors:  Yiwen Wang; Xiaoping Lei; Youyan Zhao; Jintong Tan; Jing Li; Xiaohui Gong; Liqin Shan; Qian Zhang; Qin Zhou; Yongjun Zhang
Journal:  Transl Pediatr       Date:  2021-01

2.  NLRP3 in the Cerebrospinal Fluid as a Potential Biomarker for the Diagnosis and Prognosis of Community-Acquired Bacterial Meningitis in Adults.

Authors:  Zhe Gong; Chaopeng Zhang; Yanfei Li; Lijun Jing; Ranran Duan; Yaobing Yao; Junfang Teng; Yanjie Jia
Journal:  Front Cell Infect Microbiol       Date:  2022-01-25       Impact factor: 5.293

3.  High-throughput sequencing unravels the cell heterogeneity of cerebrospinal fluid in the bacterial meningitis of children.

Authors:  Haihan Xiao; Haijuan Xiao; Yun Zhang; Lingyun Guo; Zhenzhen Dou; Linlin Liu; Liang Zhu; Wenya Feng; Bing Liu; Bing Hu; Tianming Chen; Gang Liu; Tingyi Wen
Journal:  Front Immunol       Date:  2022-09-02       Impact factor: 8.786

4.  Value of lipocalin 2 as a potential biomarker for bacterial meningitis.

Authors:  T T Thanh; C Casals-Pascual; N T H Ny; N M Ngoc; R Geskus; L N T Nhu; N T T Hong; D T Duc; D D A Thu; P N Uyen; V B Ngoc; L T M Chau; V X Quynh; N H H Hanh; N T T Thuong; L T Diem; B T B Hanh; V T T Hang; P K N Oanh; R Fischer; N H Phu; H D T Nghia; N V V Chau; N T Hoa; B M Kessler; G Thwaites; L V Tan
Journal:  Clin Microbiol Infect       Date:  2020-07-11       Impact factor: 8.067

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.